Cutaneous Naganishia albida (Cryptococcus albidus) infection: a case report and literature review.
Vítor Falcão de OliveiraAlexandre Pereira FunariMariane TabordaAdriana Satie Gonçalves Kono MagriAnna Sara LevinMarcello Mihailenko Chaves MagriPublished in: Revista do Instituto de Medicina Tropical de Sao Paulo (2023)
Naganishia albida (Cryptococcus albidus) is considered saprophytic fungi, and is rarely reported as a human pathogen. Cutaneous infections caused by non-neoformans cryptococcus are rare. We describe a case of an immunocompetent older male with cutaneous cryptococcosis caused by Naganishia albida following skin trauma, and conduct a literature review in PubMed, Lilacs, and Embase. Only six previous similar reports were found. The seven cases (including ours) were widely distributed geographically (Brazil, the US, the UK, Hungary, South Korea, and Iran), all males, and their ages varied, ranging from 14 to 86 years. Four individuals had underlying skin diseases (Sezary Syndrome, psoriasis, and skin rash without etiology) plus potentially immunosuppressive underlying conditions (diabetes mellitus, kidney transplantation, and the use of etanercept, adalimumab, and methylprednisolone). Cutaneous presentation was polymorphic, with lesions characterized as warts, ulcers, plaques, and even macules. Two patients presented disseminated disease. Serum cryptococcal antigen was negative in six patients, and diagnosis was made by fungal culture in all. There is a lack of data on optimal antifungal treatment and outcomes.
Keyphrases
- end stage renal disease
- ejection fraction
- kidney transplantation
- newly diagnosed
- rheumatoid arthritis
- chronic kidney disease
- endothelial cells
- soft tissue
- prognostic factors
- type diabetes
- low dose
- wound healing
- peritoneal dialysis
- emergency department
- physical activity
- juvenile idiopathic arthritis
- electronic health record
- high dose
- cross sectional
- deep learning
- drug induced
- combination therapy